Judy Blumstock
Founder at Diamond Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marik Hazan | M | - |
Tabula Rasa Ventures
 Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | 6 years |
| Richard Boadway | M | 73 |
Diamond Therapeutics, Inc.
 Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| Jennifer Williams | F | - |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | 22 years |
| Peter Pekos | M | - |
University of Toronto
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | 5 years |
| Robert W. E. Laurie | M | 47 |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Tanya Harding | F | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Prav Pillay | M | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Maya Albert | F | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | 4 years |
| Maria Velkova | F | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | 3 years |
| Sohaib Siddiqui | M | - |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | 4 years |
| Olav Sorenson | M | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Simeon Schnapper | M | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| James McCutcheon | M | 61 |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| Tahira Rehmatullah | F | 41 |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Elizabeth Stahura | F | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| William Hilson | M | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | - |
| Lap-Chee Tsui | M | 73 |
University of Toronto
| 41 years |
| Andrew Avi Goldenberg | M | 80 |
University of Toronto
| 42 years |
| John B. Turner | M | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
| Lisa Low | F | - |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | 17 years |
| Jamie Stiff | M | - |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto. | 22 years |
| Magenta Ceiba | F | - |
Tabula Rasa Ventures
Tabula Rasa Ventures Investment ManagersFinance Tabula Rasa Ventures LLC (Tabula Rasa Ventures) is a venture capital firm founded in 2019 by Marik Hazan. The firm is headquartered in New York. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Raf Hofstein | M | 74 |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | 11 years |
| Valdis Martinsons | M | - |
University of Toronto
| 7 years |
| Ronald Daniels | M | 64 |
University of Toronto
| 8 years |
| Hamid Mumin | M | - |
University of Toronto
| 4 years |
| Andrew Pyle | M | - |
University of Toronto
| 5 years |
| Timothy Penner | M | 68 |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | - |
| Davin Andrew Gibbins | M | - |
University of Toronto
| 5 years |
| Elizabeth M. Nash | F | - |
University of Toronto
| 5 years |
| Paul English | M | - |
University of Toronto
| - |
| Jon A. Douglas | M | 61 |
University of Toronto
| 4 years |
| Jeffrey Harley Cole | M | - |
University of Toronto
| 7 years |
| Bill Maslechko | M | 63 |
University of Toronto
| 4 years |
| Bruno M. Scherzinger | M | - |
University of Toronto
| 5 years |
| Gail Mudie | F | - |
University of Toronto
| 6 years |
| Salim Teja | M | - |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | 5 years |
| Hari Sambasivam | M | - |
University of Toronto
| 10 years |
| Michel Fattouche | M | 66 |
University of Toronto
| 5 years |
| Gerald D. Mintz | M | 71 |
University of Toronto
| 3 years |
| Stephanie B. Griffiths | F | - |
University of Toronto
| - |
| Francis Shen | M | 65 |
University of Toronto
| 5 years |
| Kin Man Lam | M | 63 |
University of Toronto
| 6 years |
| Herman Heryadi Bunjamin | M | 68 |
University of Toronto
| 6 years |
| Dave Middleton | M | - |
University of Toronto
| 4 years |
| Lynn Eplett | F | - |
University of Toronto
| 4 years |
| Leo Giovanni Ciccone | M | - |
University of Toronto
| 4 years |
| James Scarlett | M | 70 |
University of Toronto
| 3 years |
| Wendy Ford | F | - |
University of Toronto
| 4 years |
| Anthony Cina | M | 60 |
University of Toronto
| 4 years |
| Anna Marie Tham | F | 60 |
University of Toronto
| 4 years |
| Juli Morrow | F | 70 |
University of Toronto
| 3 years |
| Medhanie Tekeste | M | 61 |
University of Toronto
| 4 years |
| Paul Mancuso | M | 59 |
University of Toronto
| 4 years |
| Martin Fraser | M | - |
University of Toronto
| 5 years |
| Bing Kwong Lee | M | 69 |
University of Toronto
| 4 years |
| Brian Ostroff | M | - |
University of Toronto
| 4 years |
| Chi Yu Yu | M | 63 |
University of Toronto
| 4 years |
| Anthony Hui | M | - |
University of Toronto
| 4 years |
| Stephen Skurnac | M | 64 |
University of Toronto
| 4 years |
| Chantel Chan | F | 64 |
University of Toronto
| 4 years |
| Robert Cinits | M | 62 |
University of Toronto
| 4 years |
| Stephen C. L'Heureux | M | - |
University of Toronto
| 1 years |
| Mark F. Wheeler | M | - |
University of Toronto
| 3 years |
| Kwok Wing Chan | M | 70 |
University of Toronto
| 4 years |
| Yue Yun Lui | M | 69 |
University of Toronto
| 4 years |
| James Ngai | M | 61 |
University of Toronto
| 4 years |
| Howard Verrico | M | - |
University of Toronto
| 3 years |
| Geoff Kritzinger | M | - |
University of Toronto
| 4 years |
| Glenn Kumoi | M | 61 |
University of Toronto
| 4 years |
| Frederick S. Fisher | M | - |
University of Toronto
| 4 years |
| Barry Reiter | M | 75 |
University of Toronto
| 8 years |
| Mike Weir | M | - |
University of Toronto
| 4 years |
| Mahendra Naik | M | 65 |
University of Toronto
| 4 years |
| John McLennan | M | 71 |
University of Toronto
| 3 years |
| David William Briggs | M | - |
University of Toronto
| 4 years |
| Derek Fisher | M | - |
University of Toronto
| 3 years |
| Randy Cousins | M | - |
University of Toronto
| 4 years |
| Jim McGovern | M | 61 |
University of Toronto
| 4 years |
| Stephen E. K. Graham | M | 66 |
University of Toronto
| 4 years |
| Yau Hong Ho | M | 67 |
University of Toronto
| 4 years |
| Terry Shaunessy | M | - |
University of Toronto
| 2 years |
| Michael Vinke | M | - |
University of Toronto
| 3 years |
| Avrom Howard | M | 68 |
University of Toronto
| 4 years |
| Rudy Gobin | M | 62 |
University of Toronto
| 4 years |
| Talal Chehab | M | - |
University of Toronto
| 4 years |
| Andrew T. Wnek | M | - |
University of Toronto
| 2 years |
| Rocco Cappuccitti | M | - |
University of Toronto
| 4 years |
| Elmer Kim | M | - |
University of Toronto
| 4 years |
| Paul Petrashko | M | - |
University of Toronto
| 4 years |
| Stuart Berkowitz | M | - |
University of Toronto
| 3 years |
| Michael J. Lagopoulos | M | 67 |
University of Toronto
| 4 years |
| Ene Liis Palmer | F | - |
University of Toronto
| 3 years |
| Greg Dimmer | M | - |
University of Toronto
| 4 years |
| Richard Paul Rogers | M | - |
University of Toronto
| 4 years |
| Domenic A. Rinaldi | M | - |
University of Toronto
| 4 years |
| Terry J. Moore | M | - |
University of Toronto
| 4 years |
| Jason Lester | M | 62 |
University of Toronto
| 4 years |
| Peter Lang Fraser | M | 67 |
University of Toronto
| 4 years |
| Caroline Gillespie | F | - |
University of Toronto
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 88 | 88.00% |
| United States | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Judy Blumstock
- Personal Network
